Search for: "Chrysler Corp. v. REVIEW BOARD ETC."
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
26 Dec 2013, 1:27 pm
Where there is a substantial change in any of them (for example, through public offering of a previously private enterprise, where directors are replaced through sale to tender offer, etc.) the fundamental character of the enterprise itself changes. [read post]
